Rao, G. S. R. Subba; Prasanna, S.; Kumar, V. P. Sashi, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1986, vol. 25, p. 113 - 122
The present invention provides an early insulin secretion stimulator consisting of a triterpene represented by the following general formula (1) and/or a triterpene represented by the following general formula (2).
[where R1 represents COOH, etc., R11 and R12 represent CH2OH, etc., X1 represents hydrogen or OH and X11, X12, X21 and X22 represent OH, etc.]
The present invention provides early insulin secretion stimulators consisting of triterpenes represented by the following general formula (1) and/or triterpenes represented by the following general formula (2).
[where R
1
represents COOH, etc., R
11
and R
12
represent CH
2
OH, etc., X
1
represents hydrogen or OH and X
11
, X
12
, X
21
and X
22
represent OH, etc.]
METHOD FOR IDENTIFYING THE OAK SPECIES OF AN OAK WOOD SAMPLE
申请人:SEGUIN MOREAU & Cº
公开号:US20160011166A1
公开(公告)日:2016-01-14
The invention concerns a method for identifying the oak species including the following steps of: Providing an oak wood sample; Preparing said sample; Performing at least one analysis on the wood sample so as: to identify: from one to three molecules belonging to a 1
st
category of molecules defined by the derivatives of oleanane-type triterpenes which derive from an aglycone of empirical formula C
30
H
48
O
6
, from one to three molecules belonging to a 2
nd
category of molecules defined by the derivatives of oleanane-type triterpenes which derive from an aglycone of empirical formula C
30
H
46
O
7
, as well as derivatives of oleanane-type triterpenes which derive from an aglycone of empirical formula C
30
H
46
O
8
, then to determine the concentration of the identified molecules; Determining a ratio R; Identifying the oak species.
[EN] GLUCONEOGENESIS INHIBITING AGENT<br/>[FR] AGENTS D'INHIBITION DE LA GLUCONEOGENESE
申请人:USE TECHNO CORP
公开号:WO2006054370A1
公开(公告)日:2006-05-26
[EN] The present invention provides a gluconeogenesis inhibiting agent containing as an active ingredient corosolic acid, an analogous compound of corosolic acid, or a pharmaceutically acceptable salt thereof. [FR] La présente invention concerne un agent d'inhibition de la gluconéogenèse, contenant en tant qu'ingrédient actif de l'acide corosolique, un analogue de l'acide corosolique ou l'un de leurs sels pharmaceutiquement acceptables.